Value proposition

An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients.

ABOUT US
Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery.

Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety of oncology indications and disease biology pathways.


oncology, therapeutics, cancer medicines, tumour agnostic therapies, AI, genomics, and organoids